Filing Details

Accession Number:
0001415889-24-009995
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-03 16:21:16
Reporting Period:
2024-04-01
Accepted Time:
2024-04-03 16:21:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649094 Vaxcyte Inc. PCVX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1258693 Grant Pickering C/O Vaxcyte, Inc.
825 Industrial Road, Ste. 300
San Carlos CA 94070
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-04-01 984 $66.52 147,686 No 4 S Indirect By Children's Trust
Common Stock Disposition 2024-04-01 324 $67.27 147,362 No 4 S Indirect By Children's Trust
Common Stock Disposition 2024-04-01 890 $66.45 147,780 No 4 S Indirect By Children's Trust
Common Stock Disposition 2024-04-01 415 $67.24 147,365 No 4 S Indirect By Children's Trust
Common Stock Disposition 2024-04-01 3 $68.10 147,362 No 4 S Indirect By Children's Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Children's Trust
No 4 S Indirect By Children's Trust
No 4 S Indirect By Children's Trust
No 4 S Indirect By Children's Trust
No 4 S Indirect By Children's Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 477,847 Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.
  2. The price reported is a weighted-average price. The shares were sold at prices ranging from $66.05 to $66.97. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
  4. The price reported is a weighted-average price. The shares were sold at prices ranging from $67.14 to $68.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. The price reported is a weighted-average price. The shares were sold at prices ranging from $66.02 to $66.87. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. Shares are held directly by a trust for the benefit of the Reporting Person's son.
  7. The price reported is a weighted-average price. The shares were sold at prices ranging from $67.025 to $67.44. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.